IPCI Share Price

Open 2.73 Change Price %
High 2.89 1 Day 0.09 3.32
Low 2.71 1 Week -0.35 -11.11
Close 2.80 1 Month 0.34 13.82
Volume 145124 1 Year 0.53 23.35
52 Week High 3.35
52 Week Low 1.41
IPCI Important Levels
Resistance 2 2.97
Resistance 1 2.90
Pivot 2.80
Support 1 2.70
Support 2 2.63
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Intellipharmaceutics International Inc. (NASDAQ: IPCI)

IPCI Technical Analysis 3
As on 2nd Dec 2016 IPCI Share Price closed @ 2.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.10 & Buy for SHORT-TERM with Stoploss of 2.63 we also expect STOCK to react on Following IMPORTANT LEVELS.
IPCI Target for December
1st Target up-side 3.29
2nd Target up-side 3.63
3rd Target up-side 3.98
1st Target down-side 2.29
2nd Target down-side 1.95
3rd Target down-side 1.6
IPCI Other Details
Segment EQ
Market Capital 51980736.00
Sector Healthcare
Industry Drug Delivery
Offical website http://www.intellipharmaceutics.com
IPCI Address
IPCI
30 Worcester Road
Toronto, ON M9W 5X2
Canada
Phone: 416-798-3001
Fax: 416-798-3007
IPCI Latest News
Interactive Technical Analysis Chart Intellipharmaceutics International Inc. ( IPCI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Intellipharmaceutics International Inc.
IPCI Business Profile
Intellipharmaceutics International Inc. (IPC) is a pharmaceutical company specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technologies are a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a range of existing and new pharmaceuticals. Based on its technologies, Intellipharmaceutics has a pipeline of product candidates in various stages of development, including eight abbreviated new drug applications (ANDAs) filed with the Food and Drug Administration FDA in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.